A randomized phase II trial of adjuvant chemotherapy with UFT/LV [uracil + tegafur/folinic acid] versus S-1 following curative resection for stage III colorectal cancer

Trial Profile

A randomized phase II trial of adjuvant chemotherapy with UFT/LV [uracil + tegafur/folinic acid] versus S-1 following curative resection for stage III colorectal cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Folinic acid; Tegafur/uracil
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Oct 2016 Results published in the Anticancer Research
    • 26 Jan 2013 Results presented at the 2013 Gastrointestinal Cancers Symposium.
    • 26 Jan 2013 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top